Thrombolex
Kingston, US · Founded 2016 · Delaware corporation · 1 known investors
Founders & leadership
DB
David BonitaDirector
KH
Keegan HarperDirector
PA
Paul A. StewartDirector
SL
Sam LiangDirector
MW
Marvin WoodallExecutive Officer, Director
JC
John CerminaroExecutive Officer
CD
Clay DeMarcusDirector
MJ
Michael J. CerminaroExecutive Officer, Director
BG
Brian G. FirthExecutive Officer, Director
TR
Todd RichmondDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$32.8MraisedMar 2026 · 22 investors · Other Health CareRule 506(b)
▶$32.8MraisedMar 2026 · 22 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- David BonitaDirector
- Keegan HarperDirector
- Paul A. StewartDirector
- Sam LiangDirector
- Marvin WoodallExecutive Officer, Director
- John CerminaroExecutive Officer
- Clay DeMarcusDirector
- Michael J. CerminaroExecutive Officer, Director
- Offering amount
- $51.1M
- Amount sold
- $32.8M
- First sale
- Feb 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.2MraisedJun 2024 · 5 investors · Other Health CareRule 506(b)
▶$1.2MraisedJun 2024 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- John CerminaroExecutive Officer
- Marvin WoodallDirector
- Kelly ElliottDirector
- Todd RichmondDirector
- Michael J. CerminaroExecutive Officer, Director
- Tony LitwillerExecutive Officer
- Paul A. StewartDirector
- Offering amount
- $5M
- Amount sold
- $1.2M
- Minimum investment
- $50K
- First sale
- Jun 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.8MraisedMay 2024 · 56 investors · Other Health CareRule 506(b)
▶$4.8MraisedMay 2024 · 56 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Tony LitwillerExecutive Officer
- Paul A. StewartDirector
- Marvin WoodallDirector
- Kelly ElliottDirector
- John CerminaroExecutive Officer
- Michael J. CerminaroExecutive Officer, Director
- Todd RichmondDirector
- Offering amount
- $4.8M
- Amount sold
- $4.8M
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2MraisedAug 2022 · 50 investors · Other Health CareRule 506(b)
▶$2MraisedAug 2022 · 50 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Marvin WoodallExecutive Officer, Director
- Paul A. StewartDirector
- Michael J. CerminaroExecutive Officer, Director
- John CerminaroExecutive Officer
- Todd RichmondDirector
- Brian G. FirthExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $2M
- First sale
- Jul 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5MraisedNov 2021 · 46 investors · Other Health CareRule 506(b)
▶$5MraisedNov 2021 · 46 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Paul A. StewartDirector
- Michael J. CerminaroExecutive Officer, Director
- Brian G. FirthExecutive Officer, Director
- Todd RichmondDirector
- John CerminaroExecutive Officer
- Marvin WoodallExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$9.8MraisedFeb 2020 · 33 investors · Other Health CareRule 506(b)
▶$9.8MraisedFeb 2020 · 33 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Marvin WoodallExecutive Officer, Director, Promoter
- Michael J. CerminaroExecutive Officer, Director, Promoter
- Brian G. FirthExecutive Officer, Director
- Paul A. StewartDirector
- Todd RichmondDirector
- John CerminaroExecutive Officer
- Amount sold
- $9.8M
- First sale
- Apr 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.